TP53 and tuberculosis: Our research indicates that quercetin, luteolin, epigallocatechin gallate and beta-sitosterol may be the primary active components of GJZLP, while protein targets such as IL6, TNF, JUN, TP53 and IL1B are potential targets for GJZLP in treating tuberculosis.